Bymetric
UK company intelligence
Company Active LTD

Company profile

Alan BOYD Consultants Limited

UK company 05395927, incorporated on 17 March 2005.

Boyds | Research and Drug Development Consultancy

A global drug development consultancy translating great science into medicinal products and treatments for the benefit of patients.

Company number
05395927
Incorporated
17 Mar 2005
Companies House status
Active

Company identity

Founded / incorporated
17 March 2005

Company number 05395927

Verify at Companies House
Legal name
ALAN BOYD CONSULTANTS LIMITED
Company type
LTD
Region
North West England
Registered address
Unknown
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
35

Company events

Reference milestones and recent Companies House filing stream events.

1 event
17 Mar
2005

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2017
Funded years
2017
Age at first award
11 years

Projects

2017 Feasibility Studies

Exploiting Tumour Hypoxia in Precision Medicine: Advancing Novel Prodrug Therapies for Pancreatic Cancer with a World-leading Canadian Cancer Centre

1 Jan 2017 to 31 Mar 2017

Awarded
£17,500
Total cost £25,000

The effectiveness of cancer therapy can be limited by barriers to drug penetration at the tumour and the harbouring of drug-resistant cells in poorly oxygenated or "hypoxic" tumour regions - these becoming sources of spread. The UK company Oncotherics has developed non-toxic drugs that are designed to penetrate into these difficult to treat regions, sense...

Product types

Feasibility Studies